The crucial role of community pharmacists in balancing the impact of statins on kidney function in patients with diabetes mellitus: Recommendations for awareness, recognition, and management of diabetic nephropathy

Q2 Medicine

Obesity Medicine Pub Date : 2023-09-01 DOI:10.1016/j.obmed.2023.100506

Ammar Abdulrahman Jairoun, Chong Chee Ping, Baharudin Ibrahim

{"title":"The crucial role of community pharmacists in balancing the impact of statins on kidney function in patients with diabetes mellitus: Recommendations for awareness, recognition, and management of diabetic nephropathy","authors":"Ammar Abdulrahman Jairoun, Chong Chee Ping, Baharudin Ibrahim","doi":"10.1016/j.obmed.2023.100506","DOIUrl":null,"url":null,"abstract":"<div><p>When considering statin medication for individuals with diabetes mellitus, conducting a comprehensive risk-benefit analysis becomes crucial. Community pharmacists are vital in mitigating the potential impact of statin drugs on renal function and optimizing pharmaceutical management for diabetic patients. They employ various strategies to carefully balance the effects of statins on renal function in individuals with diabetes. Pharmacists collaborate closely with other healthcare professionals, such as physicians and nephrologists, to establish a comprehensive understanding of the patient's medical history and kidney function. Pharmacists play a crucial role in evaluating renal function and identifying underlying kidney disease by acquiring and analyzing relevant laboratory data, including serum creatinine levels and estimated glomerular filtration rate (eGFR). In conclusion, the impact of diabetes and statin drugs on renal function remains a subject of ongoing discussion in the pharmaceutical field. Community pharmacists, through collaboration with healthcare specialists, meticulous monitoring and adjustment of medication regimens, patient education, and support for lifestyle changes, optimize therapy to minimize the potential impact on renal health while ensuring optimal lipid management.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":"42 ","pages":"Article 100506"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451847623000301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

When considering statin medication for individuals with diabetes mellitus, conducting a comprehensive risk-benefit analysis becomes crucial. Community pharmacists are vital in mitigating the potential impact of statin drugs on renal function and optimizing pharmaceutical management for diabetic patients. They employ various strategies to carefully balance the effects of statins on renal function in individuals with diabetes. Pharmacists collaborate closely with other healthcare professionals, such as physicians and nephrologists, to establish a comprehensive understanding of the patient's medical history and kidney function. Pharmacists play a crucial role in evaluating renal function and identifying underlying kidney disease by acquiring and analyzing relevant laboratory data, including serum creatinine levels and estimated glomerular filtration rate (eGFR). In conclusion, the impact of diabetes and statin drugs on renal function remains a subject of ongoing discussion in the pharmaceutical field. Community pharmacists, through collaboration with healthcare specialists, meticulous monitoring and adjustment of medication regimens, patient education, and support for lifestyle changes, optimize therapy to minimize the potential impact on renal health while ensuring optimal lipid management.

查看原文本刊更多论文

社区药剂师在平衡他汀类药物对糖尿病患者肾功能的影响中的关键作用:糖尿病肾病的认识、识别和管理的建议

当考虑对糖尿病患者使用他汀类药物时，进行全面的风险-收益分析变得至关重要。社区药剂师在减轻他汀类药物对肾功能的潜在影响和优化糖尿病患者的药物管理方面至关重要。他们采用各种策略来仔细平衡他汀类药物对糖尿病患者肾功能的影响。药剂师与其他医疗保健专业人员(如医生和肾病学家)密切合作，以全面了解患者的病史和肾功能。药师通过获取和分析相关实验室数据，包括血清肌酐水平和估计的肾小球滤过率(eGFR)，在评估肾功能和识别潜在肾脏疾病方面发挥着至关重要的作用。总之，糖尿病和他汀类药物对肾功能的影响仍然是制药领域持续讨论的主题。社区药剂师通过与医疗保健专家合作，对用药方案进行细致的监测和调整，对患者进行教育，并支持改变生活方式，优化治疗方法，以最大限度地减少对肾脏健康的潜在影响，同时确保最佳的脂质管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obesity Medicine Medicine-Public Health, Environmental and Occupational Health

CiteScore

5.50

自引率

0.00%

发文量

审稿时长

40 days

期刊介绍： The official journal of the Shanghai Diabetes Institute Obesity is a disease of increasing global prevalence with serious effects on both the individual and society. Obesity Medicine focusses on health and disease, relating to the very broad spectrum of research in and impacting on humans. It is an interdisciplinary journal that addresses mechanisms of disease, epidemiology and co-morbidities. Obesity Medicine encompasses medical, societal, socioeconomic as well as preventive aspects of obesity and is aimed at researchers, practitioners and educators alike.